Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
There is uncertainty about the site(s) of action of the antidiabetic thiazolidinediones (TZDs). These drugs are agonist ligands of the transcription factor PPARγ, which is abundant in adipose tissue but is normally present at very low levels in liver and muscle. We have studied the effects of TZDs i...
Sábháilte in:
| Foilsithe in: | J Clin Invest |
|---|---|
| Príomhchruthaitheoirí: | , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
American Society for Clinical Investigation
2000
|
| Ábhair: | |
| Rochtain ar líne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC381440/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11086023/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI11245 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|